default author photo

Esma Saada-Bouzid

Centre Antoine Lacassagne

Nice

France

SCHOLARLY PAPERS

5

DOWNLOADS

350

TOTAL CITATIONS

0

Scholarly Papers (5)

1.

Cetuximab, Docetaxel and Cisplatin as First-Line Treatment in Patients with Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: Results of the GORTEC 2014-01 TPExtreme Randomized Trial

Number of pages: 31 Posted: 05 Oct 2020
Centre Antoine Lacassagne - Department of Medical Oncology, University Paris-Saclay - Biostatistic and Epidemiology Unit, Gustave Roussy, University of Claude Bernard Lyon 1 - Medical Oncology Department, Centre Antoine Lacassagne, ILC Centre Jean Bernard/Clinique Victor Hugo - Department of Medical Oncology, Institut Català de Oncologia - Department of Medical Oncology, Institut de Cancérologie de Lorraine - Department of Medical Oncology, Clinique des Ormeaux - Department of Medical Oncology, Institut de Cancérologie de l’Ouest Paul Papin - Department of Medical Oncology, Institut de Cancérologie de Montpellier - Department of Medical Oncology, Hôpital Privé le Confluent - Department of Medical Oncology, Institut de Cancérologie de l’Ouest René Gauducheau - Department of Medical Oncology, Centre Antoine Lacassagne - Department of Medical Oncology, Centre François Baclesse - Department of Medical Oncology, Gustave Roussy - Department of Head and Neck Oncology, Centre Hospitalier de Bretagne Sud - Department of Medical Oncology, Hôpital de la Croix Rousse - Department of Medical Oncology, Université de Poitiers - Medical Oncology Department, Institut Claudius Regaud - Department of Medical Oncology, Centre Eugène Marquis - Department of Medical Oncology, Centre Georges-François Leclerc - Department of Medical Oncology, University Paris-Saclay - Biostatistic and Epidemiology Unit, Gustave Roussy, University Paris-Saclay - Biostatistic and Epidemiology Unit, Gustave Roussy, Groupe d'Oncologie Radiothérapie Tête et Cou (GORTEC), Groupe d'Oncologie Radiothérapie Tête et Cou (GORTEC), Charité Comprehensive Cancer Center, Groupe d'Oncologie Radiothérapie Tête et Cou (GORTEC), Autonomous University of Barcelona - Medical Oncology Department and Independent
Downloads 111 (635,507)

Abstract:

Loading...

head and neck cancer, squamous cell carcinoma, recurrent, metastatic, Chemotherapy, cetuximab, taxane.

2.

Hpv Circulating Tumor DNA to Monitor Response to Pembrolizumab and Vorinostat Combination in Patients with Advanced Hpv-Related Squamous Cell Carcinomas

Number of pages: 28 Posted: 21 Mar 2025
Fondazione IRCCS Istituto Nazionale dei Tumori, affiliation not provided to SSRN, PSL Research University - Institut Curie, PSL Research University - Institut Curie, Centre François Baclesse - Department of Medical Oncology, PSL Research University - Institut Curie, European Institute of Oncology (IEO) IRCCS - Department of Experimental Oncology, PSL Research University - Institut Curie, PSL Research University - Institut Curie, affiliation not provided to SSRN, PSL Research University - Institut Curie, Université Lyon 1 - Faculty of Medicine Lyon-Sud, affiliation not provided to SSRN, Centre Georges-François Leclerc - Department of Medical Oncology, Institut de Cancérologie de l’Ouest René Gauducheau - Department of Medical Oncology, affiliation not provided to SSRN, University of Bordeaux - Institut Bergonié, CHU Nancy, Centre Antoine Lacassagne, Centre Jean Perrin, University of Lille II - Centre Oscar Lambret, Institut de cancérologie Strasbourg Europe (ICANS), affiliation not provided to SSRN, PSL Research University - Institut Curie, UNICANCER, Leipzig University, UNICANCER, PSL Research University - Institut Curie, affiliation not provided to SSRN, Institut Curie, PSL Research University - Institut Curie and PSL Research University - Institut Curie
Downloads 73 (852,604)

Abstract:

Loading...

circulating tumor DNA, HPV, squamous cell carcinoma, biomarker, pharmacodynamic, immunotherapy

3.

Liposarcomas: Natural History of 11132 Patients from the NETSARC Nationwide Registry

Number of pages: 26 Posted: 22 Jan 2025
University of Claude Bernard Lyon 1 - Medical Oncology Department, University of Bordeaux - Institut Bergonié, Institut Claudius Regaud, University of Montpellier - Institut régional du Cancer de Montpellier, PSL Research University - Institut Curie, CHU Timone, Institut de Cancérologie de l'Ouest, Centre Alexis Vautrin, CHU Rennes, Assistance Publique-Hopitaux de Paris (AP-HP) - Cochin Hospital, Centre Léon Berard, CHU Strasbourg, CHRU Tours, Centre Antoine Lacassagne, Centre Georges-François Leclerc, Paoli-Calmettes Institute, CHU Clermont-Ferrand, CHU de Nantes - Clinique Chirurgicale Orthopédique et Traumatologique, Centre Eugène Marquis, Institut Jean Godinot, Gustave Roussy, University of Bordeaux - Institut Bergonié, University of Lille II - Centre Oscar Lambret, Institut Claudius Regaud, Université de Toulouse, Université PSL - Department of Surgical Oncology, Centre Léon Berard, Gustave Roussy, University of Bordeaux - Institut Bergonié, University of Lille II - Centre Oscar Lambret, Institut Claudius Regaud, University of Montpellier - CHU Montpellier, PSL Research University - SIREDO Oncology Center, La Timone University Hospital, Centre Léon Bérard, Gustave Roussy, University of Lille II - Centre Oscar Lambret, Institut d’Hématologie et d’Oncologie Pédiatrique (iHOPe) - Centre Léon Bérard, Gustave Roussy, Centre Léon Bérard, Centre Léon Bérard, Institut d’Hématologie et d’Oncologie Pédiatrique (iHOPe) - Centre Léon Bérard, University of Lille II - Centre Oscar Lambret and Gustave Roussy
Downloads 71 (867,774)

Abstract:

Loading...

Sarcoma, liposarcoma, survival, registry

4.

Cabozantinib, a Promising Therapeutic Strategy for Resistant Head and Neck Squamous Cell Carcinoma Patients

Number of pages: 164 Posted: 09 Aug 2021
Université Côte d'Azur - Institute for Research on Cancer and Aging of Nice (IRCAN), Université Côte d'Azur - Institute for Research on Cancer and Aging of Nice (IRCAN), Université Cote d'Azur - Central laboratory of Pathology, Centre Antoine Lacassagne, Karolinska Institutet - Department of Microbiology, Tumor and Cell Biology (MTC), Centre Antoine Lacassagne, Université Côte d'Azur - Institute for Research on Cancer and Aging of Nice (IRCAN), Université Côte d'Azur - Institute for Research on Cancer and Aging of Nice (IRCAN), Université Côte d'Azur - Institute for Research on Cancer and Aging of Nice (IRCAN), Université Côte d'Azur - Institute for Research on Cancer and Aging of Nice (IRCAN), Centre Antoine Lacassagne, Centre Antoine Lacassagne, Karolinska Institutet - Department of Microbiology, Tumor and Cell Biology (MTC), Université Côte d'Azur - Institute for Research on Cancer and Aging of Nice (IRCAN) and Université Côte d'Azur - Institute for Research on Cancer and Aging of Nice (IRCAN)
Downloads 53 (1,031,043)

Abstract:

Loading...

AXL, c-MET, head and neck squamous cell carcinoma (HNSCC), radiotherapy, cisplatin, resistance, cabozantinib, anti-angiogenic, VEGFR inhibitor, therapy repositioning

5.

Management and Outcomes of Adolescent and Young Adult Sarcoma Patients in the French Multicenter NETSARC Database

Number of pages: 20 Posted: 11 Nov 2020
Institut de Cancérologie de l'Ouest, Gustave Roussy, Centre Oscar Lambret, Bergonié Institute, Institut Claudius Régaud IUCT Toulouse, CHU Timone, Université de Tours - CHU de Tours, Centre Léon Bérard, Gustave Roussy, Bergonié Institute, Université de Toulouse - CHU de Toulouse, CHU Lille - Centre Oscar Lambret, Centre Antoine Lacassagne, Centre Georges-Francois Leclerc, Institut Paoli-Calmettes, Centre Eugène Marquis, Institut de Cancérologie de l'Ouest, PSL Research University - SIREDO Oncology Center, PSL Research University - SIREDO Oncology Center, Assistance Publique-Hopitaux de Paris (AP-HP) - Cochin Hospital, Institut de Cancérologie de Lorraine, CHU Timone, Hôpital Necker, Hôpital Necker, Université de Tours - CHU de Tours, Centre Val d'Aurelle ICM, CHU Besançon, Institut Jean Godinot, Institute of Pediatric Hematology and Oncology, Assistance Publique-Hopitaux de Paris (AP-HP) - Cancer Research for PErsonalized Medicine (CARPEM), CHU La Réunion Mayotte, University of Limoges - CHU Limoges, Centre Jean Perrin, Centre François Baclesse, Hôpital Saint-Louis, CHU Rennes, CHU Strasbourg, Centre Henri Becquerel, Hôpital Tenon, CHU Nantes, Université de Tours - CHU de Tours, Centre Léon Bérard, Centre Léon Bérard, Bergonié Institute, Gustave Roussy, University of Claude Bernard Lyon 1 - Medical Oncology Department, Centre Léon Bérard and Centre Léon Bérard
Downloads 42 (1,157,785)

Abstract:

Loading...

Adolescents and Young Adults, AYAs, sarcoma, management, expert centers, survival, Netsarc